Login / Signup

Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome.

Suguru SaitoShima ShahbazXian LuoMohammed OsmanDesiree RedmondJan Willem Cohen TervaertLiang LiShokrollah Elahi
Published in: Frontiers in immunology (2024)
Our study findings provide a comprehensive metabolomic knowledge base and other soluble biomarkers for a better understanding of the pathophysiology of LC and suggests sarcosine and serine supplementations might have potential therapeutic implications in LC patients. Finally, our study reveals that LC disproportionally affects females more than males, as evidenced by nearly 70% of our LC patients being female.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • simultaneous determination
  • chronic kidney disease
  • healthcare
  • prognostic factors
  • liquid chromatography
  • patient reported outcomes
  • solid phase extraction